Survival, DFS, and relapse for lymphoid and myeloid malignancies. Kaplan-Meier estimates of OS, DFS, and the cumulative incidence of relapse are shown for all patients with (A-C) lymphoid malignancies and (D-F) myeloid malignancies. Outcomes are shown in red and for patients with HLA-MMUDs and in blue for patients with HLA-MUDs. P values were calculated by using log-rank tests.